A5T (p.Ala5Thr) variant of ATXN2 (Ataxin-2)

A5T (p.Ala5Thr) in ATXN2 (Ataxin-2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.37 / 1. The record also includes population frequency data.

A5T (p.Ala5Thr) variant details